TABLE 2.
Distribution of subjects and eyes according to baseline AMD severity group in the analytic dataset (N = 2697 eyes), according to progression status.
| Baseline severity group | Subjects1 (n) | Eyes (n) | Non-progressing eyes2, n (%) | Progressing eyes2, n (%) |
|---|---|---|---|---|
| Group 2 | 1052 | 1405 | 1105 (79) | 300 (21) |
| Group 3 | 885 | 1292 | 976 (75) | 316 (25) |
| Total | 17571 | 2697 | 2081 (77) | 616 (23) |
Abbreviation: AMD, age-related macular degeneration.
1
Only one eye was included for 817 subjects, while both eyes were included for 940 subjects in either baseline severity groups 2 or 3; therefore, since some subjects had one eye in group 2 and one eye in group 3 the number of subjects in the rows does not equal the total.
2
Progression defined as eye in AMD severity group 2 or group 3 at baseline progressing to higher severity groups at 2 consecutive visits over a 5 year follow-up.